Affiliation:
1. From the Department of Pathology and Laboratory Medicine, Weill Cornell Medical College, New York, NY.
Abstract
Objective—
Liver-enriched transcription factor cAMP-responsive element-binding protein H (CREBH) regulates plasma triglyceride clearance by inducing lipoprotein lipase cofactors, such as apolipoprotein A-IV (apoA-IV), apoA-V, and apoC-II. CREBH also regulates apoA-I transcription. This study aims to determine whether CREBH has a role in lipoprotein metabolism and development of atherosclerosis.
Approach and Results—
CREBH-deficient
Creb3l3
−/−
mice were bred with
Ldlr
−/−
mice creating
Ldlr
−/−
Creb3l3
−/−
double knockout mice. Mice were fed on a high-fat and high-sucrose Western diet for 20 weeks. We showed that CREBH deletion in
Ldlr
−/−
mice increased very low–density lipoprotein–associated triglyceride and cholesterol levels, consistent with the impairment of lipoprotein lipase–mediated triglyceride clearance in these mice. In contrast, high-density lipoprotein cholesterol levels were decreased in CREBH-deficient mice, which was associated with decreased production of apoA-I from the liver. The results indicate that CREBH directly activated
Apoa1
gene transcription. Accompanied by the worsened atherogenic lipid profile,
Ldlr
−/−
Creb3l3
−/−
mice developed significantly more atherosclerotic lesions in the aortas than
Ldlr
−/−
mice.
Conclusions—
We identified CREBH as an important regulator of lipoprotein metabolism and suggest that increasing hepatic CREBH activity may be a novel strategy for prevention and treatment of atherosclerosis.
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Cardiology and Cardiovascular Medicine
Cited by
21 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献